Nicotinamide Test

Your body runs on a molecule called NAD+, and nicotinamide is the raw material it uses to make more. Every time your cells produce energy, repair DNA, or respond to stress, they burn through NAD+ and release nicotinamide as a byproduct. That nicotinamide then gets recycled back into NAD+ through a process called the salvage pathway. Measuring nicotinamide in your blood gives you a window into how this recycling system is performing.

This is a newer measurement without standardized clinical cutpoints, so a single reading won't tell you as much as an established marker like blood sugar or cholesterol. But getting a baseline now, and tracking it over time, gives you early data on a system that touches everything from energy production to immune function to how well your cells handle damage.

What Nicotinamide Actually Is

Nicotinamide (also called niacinamide) is the amide form of vitamin B3. It is not a protein, enzyme, or hormone. It is a small water-soluble molecule that your body uses as a building block. Your cells make it in two ways: from the amino acid tryptophan (found in protein-rich foods) through what is called the de novo pathway, and by recycling it from NAD+ breakdown through the salvage pathway.

The salvage pathway matters most for day-to-day levels. Every time NAD+ is consumed by enzymes involved in DNA repair (called PARPs) or cellular regulation (called sirtuins), nicotinamide is released. An enzyme called NAMPT then converts it back into NAD+. This recycling loop is the primary way your cells maintain their NAD+ supply, making nicotinamide the bottleneck in a system that affects nearly every organ.

Why This Test Is Different From Standard B Vitamin Panels

Standard niacin (vitamin B3) status is assessed through urinary metabolites, not blood levels. The traditional deficiency test measures breakdown products in urine to determine whether you are getting enough dietary niacin to avoid pellagra, the classic B3 deficiency disease. Blood levels of nicotinamide are not considered reliable for diagnosing deficiency, because your body tightly regulates blood concentrations through urinary excretion. Blood NAD and NADP concentrations were not significantly depressed even in people with clinical pellagra.

This test serves a different purpose. Rather than screening for outright deficiency, blood-based nicotinamide offers a research-stage snapshot of how actively your cells are turning over NAD+. Think of it as looking at the supply side of the equation: how much raw material is circulating, available to be recycled. The clinical meaning of that number is still being worked out, but the biology it reflects is directly relevant to aging, metabolic health, and cellular resilience.

The NAD+ Connection and Aging

The reason nicotinamide has attracted interest from longevity researchers is its relationship to NAD+. Studies measuring whole-blood NAD+ (a related but different measurement from nicotinamide) consistently show that NAD+ levels decline with age. Men show higher whole-blood NAD+ levels than women before age 50 (mean 34.5 vs. 31.3 micromoles per liter, a unit for very small concentrations in blood), with this gap narrowing after 50. NAD+ content declines particularly in middle-aged men.

Whether nicotinamide follows the same age-related decline has not been as extensively studied. The age-related drop in NAD+ is thought to result from two converging forces: cells consume more NAD+ due to increased DNA damage and immune activation, while the rate-limiting recycling enzyme NAMPT becomes less active. If nicotinamide is being consumed faster than it is replenished, the whole system runs at a deficit.

Metabolic Disease Associations

A community study of 1,394 adults (average age 43) found that people in the highest quarter of whole-blood NAD levels were roughly 3 times as likely to have metabolic disease as those in the lowest quarter (odds ratio 3.01). Risk began rising at NAD levels above 31.0 micromoles per liter. This is a cross-sectional finding (a snapshot at one point in time, not a study that followed people forward), so it cannot prove that high NAD causes metabolic problems. But it suggests the relationship between NAD metabolism and metabolic health is more complex than "more is always better."

Obesity, type 2 diabetes, and chronic inflammation are all associated with disrupted NAD+ metabolism, though the direction of the disruption depends on what is being measured and in which tissue. This complexity is a reason to track trends over time rather than make decisions based on a single reading.

Cardiovascular Risk and Nicotinamide Metabolites

Some of the most provocative data come not from nicotinamide itself but from its terminal breakdown products. When your body finishes with nicotinamide, it converts it into metabolites called 2PY and 4PY. A study involving over 4,000 cardiac patients across two validation groups found that people with the highest levels of these breakdown products were roughly twice as likely to experience a major cardiovascular event over three years.

Source: Ferrell et al., Nature Medicine, 2024.

What this means for you: these findings are about downstream metabolites of nicotinamide (2PY and 4PY), not about nicotinamide itself. They suggest that excess nicotinamide metabolism, particularly at high supplementation doses, may generate breakdown products that promote vascular inflammation. This is especially relevant if you are taking high-dose B3 supplements. The finding does not mean that normal dietary nicotinamide is harmful, but it does argue for monitoring the broader NAD metabolite picture rather than looking at a single number.

N-Methylnicotinamide and Heart Disease

A related metabolite, N-methylnicotinamide (a product of nicotinamide breakdown), has also been linked to cardiovascular risk. In a study of 333 Chinese adults, those in the top third of N-methylnicotinamide levels were about 4 times as likely to have coronary artery disease as those in the lowest third (odds ratio 4.21). A separate study of 265 patients found the top third had the highest risk for impaired heart pumping function (odds ratio 6.80).

These are observational associations in specific populations, and they measured a metabolite of nicotinamide rather than nicotinamide itself. But they reinforce the pattern: how your body processes and breaks down nicotinamide may matter as much as how much is circulating.

Dietary Niacin Intake and Mortality

While downstream metabolites raise concern, dietary intake of niacin (the broader vitamin B3 family) tells a more reassuring story. An analysis of over 26,000 U.S. adults followed for a median of 9 years found that those with the highest dietary niacin intake had roughly 26% lower all-cause mortality and 27% lower cardiovascular mortality compared to those with the lowest intake. Among people with fatty liver disease, higher dietary niacin showed a continuous inverse relationship with death risk.

The apparent contradiction, dietary niacin looks protective while certain metabolites look harmful, likely reflects dose. Normal dietary intake keeps the system running smoothly. Very high supplemental doses may overwhelm the recycling pathways and produce excess harmful breakdown products. This is a theme you will see throughout the interventions section.

Reference Ranges

No major clinical guidelines establish diagnostic reference ranges for circulating nicotinamide. The values below come from analytical laboratory validation studies and should be interpreted as research-reported detection ranges, not clinical interpretation tiers with established health meanings.

These ranges reflect what the lab instruments can reliably detect, not Optimal vs. Elevated tiers. Different labs use different assay methods, which is why the ranges above vary so widely. Your most meaningful comparison is your own number over time, measured at the same lab, under similar conditions.

Kidney Function Matters

Kidney function is the single most important confounder for interpreting nicotinamide levels. Because nicotinamide is water-soluble and cleared through the kidneys, any decline in kidney function will cause nicotinamide and its metabolites to accumulate in the blood. In chronic kidney disease, NAD recycling enzymes are downregulated while breakdown products build up. Nicotinamide levels are independently associated with estimated glomerular filtration rate (eGFR), a measure of how well your kidneys filter waste. If your kidney function is impaired, a high nicotinamide reading may reflect sluggish clearance rather than healthy NAD+ metabolism.

When Results Can Be Misleading

Beyond kidney function, several factors can temporarily distort a nicotinamide reading. Intense exercise before a blood draw can lower nicotinamide, because your cells ramp up NAD+ production and pull nicotinamide out of the bloodstream to fuel that process. One study found that both high-intensity interval training and moderate continuous exercise increased cellular NAD+ while simultaneously reducing nicotinamide.

Acute illness is another major disruptor. In hospitalized COVID-19 patients, the nicotinamide metabolite 1-methylnicotinamide was elevated more than tenfold compared to healthy controls, reflecting dramatically increased NAD+ turnover during severe infection. Physical stress from cold exposure also significantly increases urinary excretion of nicotinamide metabolites. Even whether you ate before the blood draw matters: food in the stomach slows nicotinamide absorption and alters peak concentrations.

For the most interpretable result, draw blood in a fasted state, at least 48 hours after intense exercise, and when you are not acutely ill.

Tracking Your Trend

Because this biomarker lacks standardized clinical cutpoints, a single reading is nearly impossible to interpret in isolation. What gives nicotinamide measurement its value is the trend. Two or three readings over time, drawn under consistent conditions (same lab, same fasting status, similar time of day), reveal whether your NAD+ recycling system is stable, improving, or declining.

Blood NAD and NADP concentrations appear to be tightly regulated under steady-state conditions, remaining relatively constant regardless of dietary intake, with excess excreted in urine. This means that a meaningful change in your number likely reflects a real biological shift, not random noise from your last meal. That said, no studies have formally measured the intra-individual variability of nicotinamide over time, so we do not yet know exactly how much day-to-day fluctuation to expect.

Start with a baseline. If you begin a new supplement regimen targeting NAD+ (such as NR or NMN), retest in 8 to 12 weeks to see whether your specific analyte is responding. If you are simply tracking over time as part of a broader longevity strategy, an annual recheck is reasonable. Always use the same lab, since different assay methods can give different numbers for the same sample.

Nicotinamide vs. Niacin: A Common Source of Confusion

Nicotinamide and niacin (nicotinic acid) are both forms of vitamin B3, but they behave very differently in the body. Niacin causes flushing, a sometimes intense warmth and redness of the skin driven by blood vessel dilation. Nicotinamide does not cause flushing. Niacin at therapeutic doses lowers cholesterol; nicotinamide does not. Niacin carries a well-documented risk of liver damage at high doses (seen in about 20% of people on therapeutic doses); nicotinamide has a much lower liver risk, though rare cases of liver injury have occurred at doses of 3 grams per day.

There have been documented cases of patients receiving niacin when nicotinamide was intended, resulting in unexpected flushing reactions. Medical societies now explicitly warn that the two are not interchangeable. If you are supplementing or discussing your results with a provider, be precise about which form of B3 you are taking.